Zhi Q. Yao
- East Tennessee State University · Internal Medicine (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #30,374
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8568362Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2025
Linked Award Amount
$537.1K
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#30,374
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Zhi Q. Yao as a PI. Multi-PI records show the full award amount for context.
- 5R01AI177624-02R01Contact PIEngineered exosomes carrying synthetic gRNA/Cas9 targeting HBV-infected cellsEast Tennessee State University · Internal Medicine (NIH department code)$344Kaward amount
- 5R21AI179794-02R21Contact PIEngineering exosomes for new gRNA/Cas therapeutics to eliminate HBV infectionEast Tennessee State University · Internal Medicine (NIH department code)$173.8Kaward amount
- 3R01AI177624-01A1S1R01Contact PIA novel CRISPR/Cas12 system targeting HBV DNA for gene therapyEast Tennessee State University · Internal Medicine (NIH department code)$19.2Kaward amount
Award organization
Organizations that administered FY2025 awards listing Zhi Q. Yao as a PI.
FY2025 award administered by East Tennessee State University (TN).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardEast Tennessee State University
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding